Partnership announced between Truveta and Alpine Immune Sciences
Today, Truveta and Alpine Immune Sciences, Inc. announced a strategic partnership to help accelerate clinical trial recruitment for povetacicept, Alpine’s dual B cell cytokine antagonist being…
New SDOH data in Truveta Studio
LinkedIn Live: Truveta Research discusses recent maternal heart health study
The United States is one of the most dangerous high-income countries in which to give birth. Nearly every negative maternal health outcome impacts women of color…
“A passion for transforming patient outcomes” – Truveta joins the Precision Medicine World Conference
Truveta’s 2022 winter holidays
Health system spotlight: Tina Esposito, VP, CHIO, Business Intelligence and Analytics, Advocate Health
The 10 days of Truveta
‘Tis the holiday season And all through Truveta The staff dreams of our mission: Saving lives with data. It’s been a big year Much progress…
Truveta partners honored as Modern Healthcare’s 100 Most Influential
We’re proud to share that leaders from a number of our health system members have been named as Modern Healthcare’s 100 Most Influential People In Healthcare…
Truveta in the news
Children who miss early vaccines more likely to not get the MMR shot by age 2
Women with PCOS seek relief in weight-loss drugs
Weight Loss Drugs Now Account For 1 In 14 Prescriptions, Study Says
